CELC Celcuity Inc.

NEUTRAL Impact: 2/10 144
Horizon days Filed May 4, 2026 Processed 1mo ago SEC 0001000275-26-000043
Form 144 — notice of proposed sale of securities
Latest settled — T+20d
CELC ▼ -15.19% at T+20d
NEUTRAL call ✗ call lost -15.19% · α vs SPY -20.83% · entry $144.98 → $122.96
Next anchor: T+60d in 7w
Last close $87.43 (close Jun 8) · -39.70% from $144.98 entry
Entry anchored
May 4, 02:17 PM ET
via Databento tick
T+1d
-2.27%
call -2.27% · α -3.06%
$141.69
settled 5w ago
T+5d
-13.34%
call -13.34% · α -16.28%
$125.64
settled 4w ago
T+20d
-15.19%
call -15.19% · α -20.83%
$122.96
settled 8d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Director David Dalvey filed a Form 144 notice of intent to sell 25,000 shares of Celcuity Inc. common stock, with an approximate market value of $3,517,000 based on the filing date. The sale is planned under a Rule 10b5-1 trading plan established on August 19, 2025, indicating a pre-planned, non-discretionary transaction. Given the director role (not CEO/CFO), the pre-planned nature, and the relatively small proportion relative to the company's $6.1B market cap, this filing is routine and carries no material signal.

Actionable Insight

This is a routine pre-planned sale by a director under a 10b5-1 plan. No immediate trading signal. Monitor for any actual Form 4 filings to confirm execution, but no action warranted.

Key Facts

  • Insider: David Dalvey, Director
  • Shares to be sold: 25,000 shares of common stock
  • Approximate market value: $3,517,000
  • Sale intended under Rule 10b5-1 plan established on August 19, 2025
  • Filing date: May 4, 2026
  • Broker: RBC Capital Markets LLC

Financial Impact

Proposed sale of 25,000 shares worth approximately $3.5 million, representing a small fraction of the company's $6.1B market cap.

dilution

Risk Factors

  • Insider selling could be misinterpreted by the market as a negative signal, though the 10b5-1 plan mitigates this.
  • No material risk to the company from this transaction.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
88% bullish (17 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001000275-26-000043
Document: 0001000275-26-000043-index.html0001000275-26-000043
Document: 0001000275-26-000043.txt0001000275-26-000043
11 reports for CELC
Performance horizon
20% Hit rate 1 of 5 directional calls best @ T+5▲ +0.40%May 14, 2026
Filters
Rows
Reports for CELC — sortable, filterable
Type Now
Jun 8, 2026
1d ago
8-K
MIXED ★ 6/10
$87.39 awaiting T+1awaiting T+1$87.43 (+0.05%)
Jun 5, 2026
4d ago
424B5
MIXED ★ 6/10
$92.47 awaiting T+1awaiting T+1$87.43 (−5.45%)
Jun 4, 2026
6d ago
Press Release
MIXED ★ 6/10
$92.47 $88.28▼ −4.53%▼ −1.93%$87.43 (−5.45%)
Jun 3, 2026
6d ago
Press Release
BEARISH ★ 6/10
$88.95 $92.47▼ −3.96%▼ −3.56%$87.43 (+1.71%)
Jun 3, 2026
6d ago
424B5
BEARISH ★ 6/10
$88.95 $92.47▼ −3.96%▼ −3.56%$87.43 (+1.71%)
Jun 2, 2026
7d ago
8-K
BULLISH ★ 8/10
$91.42 $88.95▼ −2.70%▼ −2.01%$87.43 (−4.36%)
May 14, 2026
26d ago
Press Release
BULLISH ★ 7/10
$137.68 $132.18▼ −3.99%▼ −3.93%$87.43 (−36.50%)
May 7, 2026
4w ago
Press Release
NEUTRAL ★ 3/10
$130.71 $131.06▲ +0.27%▼ −0.56%$87.43 (−33.11%)
May 4, 2026
5w ago
144
NEUTRAL ★ 2/10
$144.98 $141.69▼ −2.27%▼ −3.06%$87.43 (−39.70%)
May 1, 2026
5w ago
Press Release
BULLISH ★ 8/10
$144.98 $141.69▼ −2.27%▼ −3.06%$87.43 (−39.70%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 9h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access